Brief Research Report
Published on 20 Sep 2021
Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory Cancers
in Molecular Medicine and Cancer Treatment
![Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory Cancers](https://www.frontiersin.org/files/myhome article library/749283/749283_Thumb_400.jpg)
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2021.749283
- 3,313 views
- 1 citation